LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices

The study is to determine the rate and cause of device replacements at 5 years post-implantation. It will assess the battery and device longevity of the Implantable Cardioverter Defibrillators (ICD) a...

Lead sponsor: Boston Scientific Corporation•51 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETED

Study Evaluating the Use of MRI on CMS Patients

NCT02513056 · Pacemaker, Implantable Cardioverter Defibrillators

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 2, 2022Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment1,600

Start dateJan 2014

Last updatedAug 2, 2022

Condition

Implantable Cardioverter Defibrillators CRT-D Cardiac Resynchronization Therapy Defibrillator

Locations shown

Alabama cardiovascular group

Birmingham, Alabama

Birmingham Heart Clinic, P.C.

Birmingham, Alabama

Phoenix Heart, PLLC

Glendale, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 2, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions